Search results :

Eptifibatide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: B01AC16

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10
Cardiac failure congestive Cardiac failure congestive common, 5.1% 5.5% x x x x
Haemorrhage Haemorrhage postmarketing, 0.02% - 19% 0% - 18.7% x x x x x x x x x x
Major bleed x x x x x x x x x
Haemoglobin Haemorrhage postmarketing, 0.02% - 19% 0% - 18.7% x x x x x x x x x x
Shock Shock common, 2.6% 2.5% x x x x
Atrioventricular block Atrioventricular block common, 1.5% 1.3% x x x x
Headache Headache 3.2% 3.2% x
Phlebitis Phlebitis common, 1.4% 1.5% x x x x
Ventricular fibrillation Ventricular fibrillation common, 1.3% 1.4% x x x x
Atrial fibrillation Atrial fibrillation common, 0.288% 0.293% x x x x
Hypotension Hypotension common, 0% 0.195% x x x x x x x x x x
Cardiac arrest Cardiac arrest common, 0.288% - 2.3% 0.391% - 2.7% x x x x
Body temperature increased Body temperature increased 1.6% 1% x
Chest pain Chest pain 0.8% - 2.12% 1.2% - 1.76% x
Pain Pain 1.2% 1.2% x
Ventricular tachycardia Ventricular tachycardia common, 0.0962% - 1.1% 0.0977% - 1.1% x x x x
Nausea Nausea 1% 1% x
Abdominal pain Abdominal pain 0.9% 1% x
Gastrointestinal pain Abdominal pain 0.9% 1% x
Gastrointestinal haemorrhage Gastrointestinal haemorrhage 0.769% 0.0977% x
Haematoma Haematoma 0.769% 0.293% x x
Haematuria Haematuria 0.0962% - 1.35% 0% - 0.781% x x x
Frank hematuria x x x x x x x
Congenital arterial malformation Arterial anomaly 0.673% 0.293% x
Retroperitoneal haemorrhage Retroperitoneal haemorrhage 0.673% 0.0977% x x x x x x x x
Cerebral ischaemia Cerebral ischaemia uncommon, 0.4% 0.5% x x x x
Haematemesis Haematemesis 0.0962% - 0.577% 0% - 0.391% x x x x x x x x x x
Coronary artery occlusion Coronary artery occlusion 0.288% 0.195% x
Dyspnoea Dyspnoea 0.192% 0% x
Epistaxis Epistaxis 0.192% 0% x
Hypersensitivity Hypersensitivity 0.192% 0.0977% x x x x x x x x
Hypertension Hypertension 0.192% 0% x
Cerebrovascular accident Cerebrovascular accident 0.192% 0.0977% x x x x x x x x
Haemorrhage intracranial Haemorrhage intracranial 0.192% 0.0977% x x x x x x x x x x
Infection Infection 0.0962% 0.0977% x
Dyspepsia Dyspepsia 0.0962% 0.195% x
Myocardial infarction Myocardial infarction 0.0962% 0.488% x
Acute coronary syndrome Myocardial infarction 0.0962% 0.488% x
Pericardial effusion Pericardial effusion 0.0962% 0.293% x
Pneumonia Pneumonia 0.0962% 0.195% x
Thrombophlebitis Thrombophlebitis 0.0962% 0.0977% x
Coronary artery disease Coronary artery disease 0.0962% 0.0977% x
Thrombocytopenia Thrombocytopenia postmarketing — 0.192% - 0.2% 0% - 0.1% x x x x x
Pulmonary haemorrhage Pulmonary haemorrhage postmarketing x x x x x x x x x
Anaphylactic shock Anaphylactic shock very rare, postmarketing x x x x x x x x x
Dermatitis Rash very rare, postmarketing x x x
Rash Rash very rare, postmarketing x x x
Urticaria Urticaria very rare, postmarketing x x x x x x x
Injury Trauma 0.02% 0% x
Cerebral infarction Cerebral infarction x x x x x x
Cardiac disorder Cardiac disorder x
Cardiac failure Cardiac failure 0% 0.488% x
Blood disorder Blood disorder x
Immune system disorder Immune system disorder x
Infarction Infarction x
Lymphoma Lymphoma x
Non-Hodgkin's lymphoma Lymphoma x
Nervous system disorder Nervous system disorder x
Neuropathy peripheral Neuropathy peripheral x
Angiopathy Angiopathy x
Injection site reaction Injection site reaction x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Haemorrhagic stroke Haemorrhagic stroke x x x x x x x
Cerebral haemorrhage Haemorrhagic stroke x x x x x x x
Haematocrit decreased Haematocrit decreased x
Liver disorder Hepatic impairment x
Renal failure Renal impairment x
Renal impairment Renal impairment x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

EPTIFIBATIDE / INTEGRILIN

Side effects:11
Source:FDA

Eptifibatide

Side effects:13
Source:FDA Structured Product Label

EPTIFIBATIDE / INTEGRILIN

Side effects:14
Source:FDA

eptifibatide / Integrilin

Side effects:14
Source:FDA

EPTIFIBATIDE / INTEGRILIN

Side effects:15
Source:FDA

eptifibatide / Integrilin

Side effects:16
Source:FDA

EPTIFIBATIDE / INTEGRILIN

Side effects:22
Source:Health Canada

eptifibatide / eptifibatide

Side effects:32
Source:EMA

Eptifibatide / INTEGRILIN INJECTION

Side effects:46
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label